RRC ID 37808
Author Satoh C, Tamura H, Yamashita T, Tsuji T, Dan K, Ogata K.
Title Aggressive characteristics of myeloblasts expressing CD7 in myelodysplastic syndromes.
Journal Leuk Res
Abstract Clinical data suggest that CD7+ myeloblasts are linked with poor prognosis in myeloid malignancies including myelodysplastic syndromes (MDS). To explore the biology behind this, we compared cell characteristics between CD34+CD7+ and CD34+CD7- myeloblasts from an MDS cell line and fresh samples from MDS patients. Compared with CD34+CD7- myeloblasts, CD34+CD7+ myeloblasts showed greater proliferative capacity, more active cell cycling, and less apoptosis. In analyses of a cell line, CD34+CD7+ myeloblasts produced CD34+CD7- myeloblasts and showed lower expressions of interleukin-8 and chemokine (C-C motif) ligand 2 genes, suggesting immaturity of these cells. These findings might underlie the clinical aggressiveness in CD7+ MDS.
Volume 33(2)
Pages 326-31
Published 2009-2-1
DOI 10.1016/j.leukres.2008.07.006
PII S0145-2126(08)00335-4
PMID 18718658
MeSH Antigens, CD7* Apoptosis Cell Cycle Cell Proliferation Chemokines, C / analysis Granulocyte Precursor Cells / metabolism* Granulocyte Precursor Cells / pathology Humans Immunophenotyping Interleukin-8 / analysis Myelodysplastic Syndromes / pathology* Tumor Cells, Cultured
IF 2.214
Times Cited 13
WOS Category HEMATOLOGY ONCOLOGY
Resource
Human and Animal Cells F-36P(RCB0775)